Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Price

Showing results (831-840 of 973) with videos related to

Pageof 98
Sort By:
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
JAMA Ophthalmology|April 26, 2014
Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty: survival, rejection risk, and visual outcomeDanny Mitry, Maninder Bhogal, Amit K Patel, et al.
Microbiology Spectrum|January 5, 2022
Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with NeuroinflammationDa Cheng, Zhenwu Luo, Xiaoyu Fu, et al.
Annals of the New York Academy of Sciences|April 25, 2002
Molecular wires, switches, and memoriesJ Chen, W Wang, J Klemic, et al.
The British Journal of Ophthalmology|June 30, 2011
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtableClaus Cursiefen, Joseph Colin, Reza Dana, et al.
Science (New York, N.Y.)|June 26, 2001
Conductance switching in single molecules through conformational changesZ J Donhauser, B A Mantooth, K F Kelly, et al.
Medical Education Online|April 26, 2015
What are the implications of implementation science for medical education?David W Price, Dianne P Wagner, N Kevin Krane, et al.
The Journal of Infectious Diseases|September 9, 2006
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremiaPeter W Hunt, P Richard Harrigan, Wei Huang, et al.
AIDS Research and Human Retroviruses|March 29, 2016
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and NoncontrollersAnupama Ganesh, Donna Lemongello, Evelyn Lee, et al.
European Journal of Pharmacology|March 31, 2006
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissueClaire Scott, Ellen M Soffin, Matthew Hill, et al.
Pageof 98

Showing results (831-840 of 973) with videos related to

Sort By:
Pageof 98
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
JAMA Ophthalmology|April 26, 2014
Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty: survival, rejection risk, and visual outcomeDanny Mitry, Maninder Bhogal, Amit K Patel, et al.
Microbiology Spectrum|January 5, 2022
Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with NeuroinflammationDa Cheng, Zhenwu Luo, Xiaoyu Fu, et al.
Annals of the New York Academy of Sciences|April 25, 2002
Molecular wires, switches, and memoriesJ Chen, W Wang, J Klemic, et al.
The British Journal of Ophthalmology|June 30, 2011
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtableClaus Cursiefen, Joseph Colin, Reza Dana, et al.
Science (New York, N.Y.)|June 26, 2001
Conductance switching in single molecules through conformational changesZ J Donhauser, B A Mantooth, K F Kelly, et al.
Medical Education Online|April 26, 2015
What are the implications of implementation science for medical education?David W Price, Dianne P Wagner, N Kevin Krane, et al.
The Journal of Infectious Diseases|September 9, 2006
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremiaPeter W Hunt, P Richard Harrigan, Wei Huang, et al.
AIDS Research and Human Retroviruses|March 29, 2016
Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and NoncontrollersAnupama Ganesh, Donna Lemongello, Evelyn Lee, et al.
European Journal of Pharmacology|March 31, 2006
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissueClaire Scott, Ellen M Soffin, Matthew Hill, et al.
Pageof 98